The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 03, 2017
Filed:
Mar. 25, 2013
Applicant:
The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, AU;
Inventors:
Assignee:
The Walter and Eliza Hall Institute of Medical Research, Parkville, AU;
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/10 (2006.01); G01N 33/68 (2006.01); G01N 33/564 (2006.01); C07K 14/705 (2006.01); C07K 16/28 (2006.01); G01N 33/50 (2006.01); C12N 5/0783 (2010.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
G01N 33/6896 (2013.01); C07K 14/70592 (2013.01); C07K 16/2803 (2013.01); C07K 16/2863 (2013.01); C07K 16/2866 (2013.01); C07K 16/2893 (2013.01); C12N 5/0637 (2013.01); G01N 33/502 (2013.01); G01N 33/564 (2013.01); G01N 33/6872 (2013.01); G01N 33/6893 (2013.01); A61K 38/00 (2013.01); C07K 2317/76 (2013.01); C07K 2319/30 (2013.01); G01N 2333/70592 (2013.01); G01N 2800/26 (2013.01); G01N 2800/285 (2013.01); G01N 2800/50 (2013.01); G01N 2800/52 (2013.01);
Abstract
The present disclosure relates to the use of a soluble CD52 glycoprotein in treating diseases regulated by effector T-cells, for example sepsis or multiple sclerosis. The present disclosure also relates to diagnostic methods based on the detection of CD52 expression levels in a subject.